课题基金 / 基金详情

Mechanisms of glioblastoma multiforme invasion: the role of STAT3

Mechanisms of glioblastoma multiforme invasion: the role of STAT3
多形性胶质母细胞瘤侵袭机制:STAT3的作用
批准号:
7158293
负责人:
Albert Hong-Jae Kim
金额:
$5.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2008-06-30

项目摘要

项目成果

Albert Hong-Jae Kim的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Among gliomas, the most common primary brain tumor in adults, glioblastoma multiforme (GBM) is the most malignant. Despite advances in surgery, chemotherapy, and radiation, GBM remains a devastating disease. A hallmark of GBM is ts ability to infiltrate white matter tracts, but little is known about the molecular mechanisms underlying the acquisition of nvasive characteristics. PTEN, which encodes a negative regulator of the phosphoinositide-3 kinase pathway, is commonly mutated in GBMs and has been implicated in regulation of tumor migration. The underlying hypothesis of this proposal is that abnormalities in processes that determine normal glial development contribute to malignant transformation. Previous studies have identified a critical role for activation of STAT3, a transcription factor, in the differentiation of neural stem cells into astrocytes. In preliminary data, STAT3 loss increased the migration of murine astrocytes in vitro. Moreover, in human GBM samples, low PTEN expression correlated with low STAT3 activity. Together, these results raise the intriguing possibility that STAT3 inhibits invasiveness in PTEN-deficient GBMs. The specific aims of this study are: 1) to test the role of STAT3 in GBM invasiveness in brain slice assay and in vivo, 2) to dentify STAT3-responsive genes that control GBM migration using expression array analysis, and 3) to identify novel cell-intrinsic mechanisms that regulate GBM invasiveness through an RNA interference-based screen. These aims will be pursued using a combination of molecular biology, cell culture, brain slice preparation, and in vivo approaches. Completion of these aims will elucidate the role of STAT3 in GBM invasiveness and potentially reveal new therapeutic argets against GBM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of SOX2 Regulation in Glioblastoma
  • 批准号:
    10504032
  • 项目类别:
  • 资助金额:
    $37.64万
  • 财政年份:
    2022
  • 负责人:
    Albert Hong-Jae Kim
  • 依托单位:
Mechanisms of SOX2 Regulation in Glioblastoma
  • 批准号:
    10676179
  • 项目类别:
  • 资助金额:
    $38.22万
  • 财政年份:
    2022
  • 负责人:
    Albert Hong-Jae Kim
  • 依托单位:
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
  • 批准号:
    10654813
  • 项目类别:
  • 资助金额:
    $44.49万
  • 财政年份:
    2019
  • 负责人:
    Albert Hong-Jae Kim
  • 依托单位:
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
  • 批准号:
    10448244
  • 项目类别:
  • 资助金额:
    $47.81万
  • 财政年份:
    2019
  • 负责人:
    Albert Hong-Jae Kim
  • 依托单位:
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
  • 批准号:
    82371465
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李龙宣
  • 依托单位:
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位: